December 9, 2025 · Form 4 insider transaction
Peyer James sold 395 shares of SNSE at $8.04 per share, a transaction worth $3.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.